Stay updated on CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.

Latest updates to the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page
- Check2 days agoChange DetectedUpdated to Revision: v3.0.2 (from v3.0.1); removed the 'Back to Top' link; no other substantive content changes.SummaryDifference0.2%
- Check9 days agoChange DetectedThe page has been updated to include a new research article on improvements in health-related quality of life for patients with transfusion-dependent beta-thalassemia, along with a revision update from v3.0.0 to v3.0.1.SummaryDifference3%
- Check16 days agoChange DetectedThe web page has been updated to include specific drug information for Exagamglogene Autotemcel and details about various genetic and blood disorders, while also removing some location-related terms and previous revision information.SummaryDifference6%
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX001 in β-Thalassemia: Safety/Efficacy Clinical Trial page.